Kalvista Pharmaceuticals Inc (KALV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 04/30
| 06-2014 | 04-2014 | 03-2014 | 01-2014 | 12-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,650 | N/A | -2,015 | N/A | -5,670 |
| Depreciation Amortization | 20 | 50 | 58 | N/A | 20 |
| Accounts payable and accrued liabilities | 275 | N/A | 24 | N/A | N/A |
| Other Working Capital | 545 | 60 | 68 | N/A | 460 |
| Other Operating Activity | 118 | 130 | 111 | 0 | 340 |
| Operating Cash Flow | $-3,692 | $240 | $-1,754 | $N/A | $-4,850 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -76 | -1 | -1 | N/A | -10 |
| Investing Cash Flow | $-76 | $-1 | $-1 | $N/A | $-10 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 1,250 | N/A | 1,250 | N/A | N/A |
| Common Stock Issued | 195 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -282 | 1,250 | 0 | 0 | 6,410 |
| Financing Cash Flow | $1,163 | $1,250 | $1,250 | $N/A | $6,410 |
| Beginning Cash Position | 9,781 | N/A | 9,781 | N/A | 8,240 |
| End Cash Position | 7,176 | N/A | 9,276 | N/A | 9,780 |
| Net Cash Flow | $-2,605 | $1,489 | $-505 | $N/A | $1,530 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,692 | 240 | -1,754 | N/A | -4,850 |
| Capital Expenditure | -76 | N/A | -1 | N/A | N/A |
| Free Cash Flow | -3,768 | 240 | -1,755 | 0 | -4,850 |